Wuhan Mingde Biotechnology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- The Company disclosed the "Announcement on Planning Major Asset Restructuring and Signing the Equity Acquisition Intent Agreement" (Announcement No. 2025-056) on December 31, 2025, explaining the relevant matters involved in this transaction.
- The relevant work for this transaction is actively progressing, and the parties involved have not yet signed a formal agreement. There remains significant uncertainty regarding this transaction, and the Company will fulfill its information disclosure obligations in stages based on the progress of relevant matters. Investors are advised to pay attention to the Company's subsequent announcements and be aware of investment risks.